Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

cyclophosphamide/fluorouracil/fluoxymesterone/methotrexate

Known as: CMFH, CTX/5-FU/FXM/MTX 
 
National Institutes of Health

Related topics

Related topics

4 relations
CyclophosphamideFluorouracilFluoxymesteroneMethotrexate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
A prospective evaluation of chemohormonal therapy remission maintenance in advanced breast cancer
SummaryFrom October 1973 to October 1977 the ECOG prospectively evaluated cyclophosphamide, methotrexate, and fluorouracil (CMF… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
1993
1993
Nuclear DNA content of isolated crypts of background colonic mucosa from patients with familial adenomatous polyposis and sporadic colorectal cancer.
The DNA content of the upper one third of the crypt epithelium was compared with that of the lower two thirds in the background… Expand
1986
1986
A clinical trial of homoharringtonine in the treatment of advanced breast cancer.
Abstract Two combination chemotherapy protocols, CMF (cyclophosphamide, methotrexate, fluorouracil) and CMFH (CMF plus… Expand
1986
1986
A clinical trial of homoharringtonine in the treatment of advanced breast cancer.
Two combination chemotherapy protocols, CMF (cyclophosphamide, methotrexate, fluorouracil) and CMFH (CMF plus homoharringtonine… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE